Australian Fish Genomics Initiative: 2024 Request for Partnership Now Open
Bioplatforms Australia, in collaboration with Minderoo Foundation, is pleased to announce the opening of the 2024 Request for Partnership for the Australian Fish Genomics Initiative.
EMBL Australia joins NCRIS Health Group to enhance collaborative health research
Bioplatforms Australia is proud to collaborate with EMBL Australia and our national research partners in advancing health research for Australia.
Plant Pathogen Initiative – Request for Partnership 2024 is now open
The Plant Pathogen Omics Initiative has opened its 2024 Request for Partnership.
Major breakthrough in type 1 diabetes: PromarkerD predicts kidney disease
Proteomics International Laboratories' Promarker D test effectively forecasts renal decline in patients with type 1 diabetes.
Parliamentary Friends of Science event highlights Australia’s synthetic biology future
At a recent Parliamentary Friends of Science event, synthetic biology took centre stage as a transformative force ready to reshape industries and tackle global challenges.
Advancing human genomics research through enhanced data sharing
The Bioplatforms-supported Australian BioCommons is leading key projects to improve access to human genomics data.
Drug Target Identification node establishment at the Monash Proteomics and Metabolomics Platform
The Bioplatforms-supported Monash Proteomics & Metabolomics Platform has launched Australia’s first Drug Target Identification node, thanks to a successful MRFF grant led by Prof. Darren Creek.
Pioneering Australian vaccine innovation in the wake of Covid-19
Sementis is revolutionising vaccine development by rapidly addressing infectious diseases such as COVID-19, Chikungunya, and Zika in collaboration with SAGC and the Experimental Therapeutics Laboratory.